Can't wait for them to seek regulatory approvals for cartilage and tendon growth - possible diversification in revenue will improve valuations.
Also like the fact that they are open to:
1) Sports segment - as I said in my previous post that market still uses the traditional methods, and
2) Animal health (not a focus of many companies)
All this will support SP - only they need to go find that CASH now.
Can't wait for them to seek regulatory approvals for cartilage...
Add OSX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.4¢ |
Change
0.003(4.92%) |
Mkt cap ! $7.319M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.6¢ | 5.9¢ | $173.8K | 2.783M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 373082 | 6.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.4¢ | 9999 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.3¢ |
Change
0.003 ( 5.53 %) |
||||
| Open | High | Low | Volume | ||
| 6.0¢ | 6.6¢ | 5.9¢ | 550208 | ||
| Last updated 15.57pm 14/06/2024 ? | |||||
| OSX (ASX) Chart |